Cargando…
Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway
Aim: Roles of fibroblast growth factor 23 (FGF23) in endothelial dysfunction remain controversial, and evidence from population-based studies is lacking. The present study aimed to explore the effects of FGF23 on endothelial dysfunction on the basis of both clinical data of patients with coronary ar...
Autores principales: | Guo, Li-wei, Wang, Yi-kai, Li, Shi-jie, Yin, Guo-tian, Li, Duan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925204/ https://www.ncbi.nlm.nih.gov/pubmed/35314565 http://dx.doi.org/10.5551/jat.63460 |
Ejemplares similares
-
A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017) -
The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment
por: Nie, Jingwen, et al.
Publicado: (2021) -
Fibroblast growth factor 23 level modulates the hepatocyte’s alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκB
por: Mattinzoli, Deborah, et al.
Publicado: (2022) -
Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor‐23
por: Ng, Nicholas Beng Hui, et al.
Publicado: (2022) -
Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway
por: Hu, Ji, et al.
Publicado: (2021)